在KRAS突变癌症中精确免疫调节:拼图的最后一块?
Shenao Fu1, Jiayao Ma1, Changjing Cai1
1Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
概括
针对KRAS突变的向疗法正在推进,但仍然存在挑战. 了解KRAS突变如何影响瘤免疫微环境是开发有效免疫疗法的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 针对KRAS突变的向疗法已经发展,超越了"不可抗药"的概念.
- 尽管取得了进展,但针对KRAS的疗法仍面临诸如耐药性,有效性和毒性等挑战.
- 克拉斯突变显著改变瘤免疫微环境,影响免疫治疗结果.
研究的目的:
- 审查KRAS向治疗的历史和挑战.
- 总结KRAS突变对瘤免疫微环境的影响.
- 探索基于KRAS突变亚型的潜在免疫治疗策略.
主要方法:
- 对针对KRAS的治疗方法及其挑战的文献综述.
- 对KRAS突变及其对瘤免疫微环境的影响的研究分析.
- 在不同KRAS突变和共突变亚型中对免疫微环境的比较审查.
主要成果:
- 由于最近的治疗进展,KRAS突变不再被认为是"不可抗药的".
- 克拉斯突变极大地影响瘤免疫微环境,为免疫治疗带来机遇和挑战.
- 不同的KRAS突变类型和共同突变导致不同的免疫微环境,影响免疫疗法选择.
结论:
- 由于当前针对KRAS的治疗方法的局限性,替代性治疗方式至关重要.
- 根据特定的KRAS突变档案定制免疫疗法对于优化治疗疗效至关重要.
- 对KRAS突变驱动的免疫变化的进一步研究可以指导未来的癌症免疫疗法开发.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.1K
Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K


